Revuforj first-mover edge, pipeline catalysts (Niktimvo), and profitability path amid misses. Click here to read more about ...
The Cystic Fibrosis Foundation organised a multidisciplinary committee to develop this Position Paper to outline current ...
It’s summer and two things are certain – the heat and travel. Vacation time is here and I am asked regularly what can be done ...
MarketBeat on MSN
Syndax Pharmaceuticals Maps Growth Beyond Revuforj With Lung Cancer, Myelofibrosis Push
Key Points Interested in Syndax Pharmaceuticals, Inc.? Here are five stocks we like better. Syndax Pharmaceuticals is ...
13hon MSN
What is a Pandemic?
A pandemic is a disease outbreak of global proportions, with potentially catastrophic consequences. Here is a look at some of ...
Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ('Inhibikase” or 'Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension ('PAH”), today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results